Update expected from Glaxo on swine flu drugs

One of the firms at the forefront of fighting the swine flu pandemic is today expected to give an update on its anti H1N1 drugs.

Update expected from Glaxo on swine flu drugs

One of the firms at the forefront of fighting the swine flu pandemic is today expected to give an update on its anti H1N1 drugs.

GlaxoSmithKline is one of several companies charged with producing a vaccine for H1N1 after the World Health Organisation (WHO) declared it a pandemic last month.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

CONNECT WITH US TODAY

Be the first to know the latest news and updates

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited